Liver cirrhosis is a late-stage liver disease characterized ... visible spider-like blood vessels, and palm redness. Treatment focuses on addressing underlying causes, such as alcohol dependency ...

Cirrhosis is a type of liver disease where scarring has led to ... One of the newer types of treatment is the TIPS procedure, which helps to reduce the portal hypertension that contributes to ...

Causes of compensated cirrhosis may include nonalcoholic fatty liver disease (NAFLD), alcohol-related liver disease, and chronic hepatitis B and C. Treatment for the condition will depend on the ...

Sequana Medical Announces US FDA Approval of alfapump® for the Treatment of Recurrent or Refractory Ascites due to Liver Cirrhosisalfapump® is ...

The only thing that can cure cirrhosis is a liver transplant. Treatment aims to manage symptoms. Along with quitting drinking, options include: seeking medical help for alcohol dependency low ...

The global cirrhosis management market is projected to grow from US$ 725 million in 2023 to US$ 1,052.3 million by 2033, with ...

There are limited effective treatment options, resulting in poor clinical ... treatment of recurrent or refractory ascites due to liver cirrhosis in December 2024, following the grant of FDA ...

Purpose Published evidence on the incidence and predictors of venous thromboembolism (VTE) in patients with cirrhosis of the liver is reviewed. Summary The frequently observed phenomenon of ...

Then came the 2016 accelerated approval of the farnesoid X receptor (FXR) agonist obeticholic acid (Ocaliva) as a second-line treatment ... advanced liver disease like decompensated cirrhosis ...

US FDA grants fast track designation to Lipocine’s LPCN 1148 as a treatment for sarcopenia in patients with decompensated cirrhosis: Salt Lake City Thursday, December 19, 2024, ...

LPCN 1148, an oral prodrug of bioidentical testosterone, was recently studied in a proof-of-concept (POC) Phase 2 study in patients with decompensated cirrhosis. Treatment with LPCN 1148 in the ...